跳至主要内容
临床试验/NCT01344291
NCT01344291Unknown1 期

Turmeric Effect on Reduction of Serum Prolactin and Related Hormonal Change and Adenoma Size in Prolactinoma Patients

Mashhad University of Medical Sciences2 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2011年7月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
30
试验地点
2
主要终点
serum prolactin level

研究概览

简要总结

Prolactinoma is the most prevalent anterior hypophysis tumor. The principal treatment for this disorder is Dopamine agonist drugs including bromocriptin and Cabergoline. However, 50% of Bromocriptin treated and 17% of Cabergoline treated patients are resistant to these drugs. Curcumin is the main derivative of turmeric ,an old spice which is used frequently in Indian and Iranian cuisine. It has been proved that curcumin can reduce mammotrope cells proliferation and also intracellular hormone production. The purpose of this study is to evaluate the effect of turmeric on prolactinoma patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • hyperprolactinemia
  • microprolactinoma

排除标准

  • pregnancy
  • macroadenoma
  • neurologic signs due to tumor

结局指标

主要结局

serum prolactin level

时间窗: 2weeks and one month after treatment

次要结局

  • change in LH,FSH and estradiol from baseline(one month ofter treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Haleh Rokni Yazdi

assisstant professor

Mashhad University of Medical Sciences

研究点 (2)

Loading locations...

相似试验